Medicus Pharma Ltd MDCXW Advances FDA Discussions and Broadens 2026 Clinical Development Plans US Stock Futures Stagnate as Investors Await Hormuz Resolution Update What Canary SUISs 880 Decline Means for Investors 20260515 Intelligent IPM Q1 2026 Results Fall Short EPS 004 Revenue NA Globalstar GSAT Q1 2026 Earnings Miss Sparks Concern 2026 CNBC Disruptor 50 AI Companies Dominate Rankings as New Leader Emerges Ultragenyx Pharmaceutical RARE at 2639 Buy Sell or Hold 20260514